INSIGHTS AND PERSPECTIVES

WASHINGTON — Nearly 1,000 biotech drugs and vaccines for more than 100 diseases are currently under development, according to a new report.

OutcomesMTM, a medication therapy management delivery system, last week recognized its top chain and independent pharmacies for 2012. Walgreens and Kerr Drug were named top large pharmacy chain and top regional pharmacy chain, respectively. 

MTM matters, and people are keeping score. And it's something you can expect to see more of in the age of accountable care and star-based quality ratings.  

ST. LOUIS — While the country's spending on specialty drugs increased by 18.4% in 2012, spending on traditional drugs fell for the first time in 20 years, according to a report by Express Scripts.

Just about every healthcare practitioner recommends over-the-counter medicines to their patients. And nearly 3-out-of-4 make that OTC recommendation as the first therapy option, according to a recent survey released by the Consumer Healthcare Products Association. 

This is another proof point that OTC medicines play an important role in holding down cost. 

BERLIN — The global market for mobile health app services is expected to reach $26 billion by 2017 as smartphone applications allow the mhealth industry to successfully monetize its services, according to a new report.

Global Mobile Health Market Report 2013-2017, announced Friday by Berlin-based mobile market research firm Research2guidance, found that top mhealth publishers manage to generate more than 3 million free and 300,000 paid downloads in the United States on the Apple iOS platform.

The number of Americans who want technology to play a role in their healthcare is growing, as up to 64% of Americans use online health resources, and 40% use them to self-diagnose, according to a new survey conducted by the Atlantic and GlaxoSmithKline. Yet while 94% of those using online resources consider them important to their health, only 12% report contacting doctors via email or text message regarding a health question.

ALEXANDRIA, Va. — The cost of diabetes has increased by more than $70 billion over the past five years, according to new research from the American Diabetes Association.

The ADA announced the release of a report estimating that the total costs of diagnosed diabetes had risen 41%, from 2007's $174 billion to $245 billion in 2012. The report, Economic Costs of Diabetes in the U.S. in 2012, was commissioned by the ADA and addresses increased financial burden, health resources used and lost productivity associated with the disease.

CHICAGO — The percentage of adults in the United States who say they want to reduce or eliminate gluten from their diets reached a new high this January, according to a new study.

The NPD Group, a market research firm, has tracked efforts by Americans to reduce gluten intake since 2009, finding that 30% of adults claimed to cut down on gluten or avoid it entirely in January.